Disease: Hepatorenal syndrome
- A case-cohort study of left ventricular diastolic dysfunction in patients with cirrhosis: the liver-heart axis
- A Fatal Case of Presumptive Diagnosis of Leptospirosis Involving the Central Nervous System
- A hospitalist's approach to managing acute kidney injury (hepatorenal syndrome) in cirrhosis
- Acute Kidney Injury and Hepatorenal Syndrome in Patients with Cirrhosis
- Acute kidney injury in acute liver failure: A narrative review
- Acute kidney injury in patients with cirrhosis - practical summary
- Acute kidney injury in patients with Cirrhosis: Acute disease quality Initiative (ADQI) and international Club of ascites (ICA) joint multidisciplinary consensus meeting
- AGA Clinical Practice Update on the Use of Vasoactive Drugs and Intravenous Albumin in Cirrhosis: Expert Review
- Albumin: a comprehensive review and practical guideline for clinical use
- Allopurinol Prevents Cirrhosis-Related Complications: A Quadruple Blind Placebo-Controlled Trial
- Analyzing the utility of renal replacement therapy to manage hepatorenal syndrome in alcoholic hepatitis without liver transplantation: a nationwide analysis
- Apheresis Techniques for the Treatment of Hyperbilirubinemia in the Nephrology Unit
- Aprepitant boasted a protective effect against olanzapine-induced metabolic syndrome and its subsequent hepatic, renal, and ovarian dysfunction; Role of IGF(1)/p-AKT/FOXO(1) and NFkappaB/IL-1beta/TNF-alpha signaling pathways in female Wistar albino rats
- Aprepitant boasted a protective effect against olanzapine-induced metabolic syndrome and its subsequent hepatic, renal, and ovarian dysfunction; Role of IGF<sub>1</sub>/p-AKT/FOXO<sub>1</sub> and NFκB/IL-1β/TNF-α signaling pathways
- Association of left ventricular diastolic dysfunction with inflammatory activity, renal dysfunction, and liver-related mortality in patients with cirrhosis and ascites
- Association of non-selective β blockers with the development of renal dysfunction in liver cirrhosis: a systematic review and meta-analysis
- Association of serum sodium and 24-hour urinary sodium level with the severity and complications of ascites in cirrhotic patients
- B-Blockers in Liver Cirrhosis: A Wonder Drug for Every Stage of Portal Hypertension? A Narrative Review
- Beta-blockers or Placebo for Primary Prophylaxis (BOPPP) of oesophageal varices: study protocol for a randomised controlled trial
- Cardiomyopathy in cirrhosis: From pathophysiology to clinical care
- Characteristics and Related Factors of Bacterial Infection Among Patients With Cirrhosis
- Cholemic Nephropathy: Role in Acute Kidney Injury in Cholestasis and Cirrhosis
- Comparative efficacy of terlipressin and norepinephrine for treatment of hepatorenal syndrome-acute kidney injury: A systematic review and meta-analysis
- Controversies in terlipressin and transplantation in the United States: How do we MELD the two?
- Delhi Model: A New Tool for Predicting Response to Terlipressin in Hepatorenal Syndrome-Acute Kidney Injury
- Deranged Biochemical Markers As Early Predictors for the Development of Hepatorenal Syndrome in Patients With Alcoholic Liver Cirrhosis
- Droxidopa or Atomoxetine for Refractory Hypotension in Critically Ill Cardiothoracic Surgery Patients
- Early Versus Standard Initiation of Terlipressin for Acute Kidney Injury in ACLF: A Randomized Controlled Trial (eTerli Study)
- Effect of albumin infusion on oxidative albumin modification and albumin binding capacity in chronic liver failure
- Efficacy and safety of terlipressin and albumin vs. noradrenaline and albumin in adult patients with hepatorenal syndrome: A systematic review and meta-analysis
- Erratum: Role of Terlipressin in Patients With Hepatorenal Syndrome-Acute Kidney Injury Admitted to the ICU: A Substudy of the CONFIRM Trial: Erratum
- Evaluation of terlipressin-related patient outcomes in hepatorenal syndrome-acute kidney injury using point-of-care echocardiography
- Fanconi syndrome with hepatorenal karyomegaly in a young Sphynx cat
- From past to present to future: Terlipressin and hepatorenal syndrome-acute kidney injury
- Granulocyte colony-stimulating factor plus pentoxifylline increases short-term survival in patients with severe alcoholic hepatitis: a network meta-analysis
- Gut-Liver Axis Dysregulation in Portal Hypertension: Emerging Frontiers
- Healthcare Resource Utilization and Goals of Care Discussions in Patients with Cirrhosis and Acute Kidney Injury
- Helicobacter pylori Infection and Complications of Cirrhosis
- Hepatitis A hospitalisations in the United States and risk factors for inpatient mortality: A nationwide population study, 1998-2020
- Hepato-Cardio-Renal Syndrome
- Hepatocardiorenal syndrome in liver cirrhosis: Recognition of a new entity?
- Hepatorenal Syndrome
- Hepatorenal Syndrome in Cirrhosis
- Hepatorenal syndrome in the intensive care unit
- Hepatorenal Syndrome Type 1: Diagnosis and Treatment
- Hepatorenal Syndrome-Novel Insights into Diagnostics and Treatment
- High-dose proton pump inhibitor treatment is associated with a higher mortality in cirrhotic patients: A multicentre study
- Importance about use of high-throughput sequencing in pediatric: case report of a patient with Fanconi-Bickel syndrome
- Improving Outcomes in Hepatorenal Syndrome-Acute Kidney Injury With Early Diagnoses and Implementation of Approved Treatment Regimens
- Influence of metabolic dysfunction-associated fatty liver disease on the prognosis of patients with HBV-related acute-on-chronic liver failure
- INFUSE: Rationale and design of a multi-center, open label, collaborative study to treat HRS-AKI with continuous terlipressin infusion
- Key Components of Successful Management of Acute Fatty Liver of Pregnancy: A Case Report and Literature Review
- Kidney Dysfunction in the Setting of Liver Failure: Core Curriculum 2024
- Kidney involvement in Wilson's disease: a review of the literature
- Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial
- Letter to the Editor: Is right heart assessment vital for evaluating Terlipressin-related outcomes in Hepatorenal Syndrome-AKI?
- Liver cirrhosis and complications from the perspective of dysbiosis
- Lower uromodulin serum levels are associated with poorer prognosis in patients with cirrhosis and hepatorenal syndrome type 2
- Management of hepatorenal syndrome and associated outcomes: a systematic reviews
- National frequency, trends, and healthcare burden of care fragmentation in readmissions for end-stage liver disease in the USA
- Neutrophil Gelatinase-associated Lipocalin Predicts Short-term Outcomes in Decompensated Cirrhosis With Acute Kidney Injury
- Novel predictors of response to therapy with terlipressin and albumin in hepatorenal syndrome-acute kidney injury
- Optimal resting heart rate and ascites-related death in patients with cirrhosis and ascites using nonselective beta-blockers (ORCA)
- Optimal Resting heart rate on ascites-related death in patients with Cirrhosis and Ascites using nonselective beta blockers (ORCA)
- Optimization of Kidney Health in Liver Transplant Candidates: Pretransplant Considerations and Modalities
- Outcomes among patients with hepatorenal syndrome based on hospital teaching and transplant status: Analysis of 159 845 hospitalizations
- Oxidative Mechanisms and Cardiovascular Abnormalities of Cirrhosis and Portal Hypertension
- Pathophysiology of Hepatorenal Syndrome
- Portal Hypertension among Patients with Chronic Liver Disease Admitted to the Department of Internal Medicine of a Tertiary Care Centre
- Predictors of Short-term Mortality in Patients of Cirrhosis of Liver Presenting as Acute Kidney Injury: An In-hospital Prospective Observational Study
- Prognostic nutritional index application value for acute-on-chronic liver failure co-infection
- Prospective validation of the EASL management algorithm for acute kidney injury in cirrhosis
- Pulmonary Embolization After Gastric Varices Obliteration
- Renal Replacement Therapy in Cirrhosis: A Contemporary Review
- Reply: Is right heart assessment vital for evaluating terlipressin-related outcomes in Hepatorenal Syndrome-AKI ?
- Research Progress in the Roles of Sympathetic Nervous System in Liver Cirrhosis and Its Complications
- Review article: Recent advances in ascites and acute kidney injury management in cirrhosis
- Role of albumin infusion in cirrhosis-associated complications
- Ruxolitinib-loaded cytokine nanosponge alleviated the cytokine storm and dampened macrophage overactivation for the treatment of hemophagocytic lymphohistiocytosis
- Securing the diagnosis of HRS-AKI: implications for current therapies
- Soluble suppression of tumorigenicity 2 is a potential predictor of post-liver transplant renal outcomes
- Study of liver cirrhosis over twenty consecutive years in adults in Southern China
- Study of prevalence, risk factors for acute kidney injury, and mortality in liver cirrhosis patients
- Subcutaneous therapy for portal hypertension: PHIN-214, a partial vasopressin receptor 1A agonist
- Sulfasalazine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) coinfected with COVID-19 complicated by hemophagocytic lymphohistiocytosis: a case report
- Teduglutide-induced acute gastric mucosal necrosis in short bowel syndrome with hepatorenal failure: Case report
- Terlipressin for hepatorenal syndrome
- Terlipressin for hepatorenal syndrome: The practical choice for clinicians
- Terlipressin for the Prevention and Treatment of Renal Decline in Hepatorenal Syndrome: A Drug Profile
- Terlipressin in the management of adults with hepatorenal syndrome-acute kidney injury (HRS-AKI)
- The first autopsy case of Epstein-Barr virus-positive marginal zone lymphoma that deteriorated after COVID-19 vaccination
- The Impact of Race and Sex on the Clinical Outcomes of Homeless Patients With Alcoholic Liver Disease: Propensity Score Matched Analysis of US Hospitals
- The landscape of inpatient admissions for alcoholic hepatitis in the era of early liver transplantation
- Transjugular intrahepatic portosystemic shunts for adults with hepatorenal syndrome
- Treatment-Related Cost Analysis of Terlipressin for Adults with Hepatorenal Syndrome with Rapid Reduction in Kidney Function
- Use of Terlipressin in AKI Associated Hepatorenal Syndrome: CON
- Use of Terlipressin in AKI Associated with Hepatorenal Syndrome: COMMENTARY
- Use of Terlipressin in AKI Associated with Hepatorenal Syndrome: PRO
- Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease
- What is the role for terlipressin in hepatorenal syndrome?